Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid ret...
HC Wainwright & Co. analyst Robert Burns downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Neutral and lowers the...
Canaccord Genuity analyst Bill Maughan downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Hold and lowers the price ta...
Jones Trading analyst Justin Walsh downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Hold.
